Genomics England Taps Icon to Manage 100K Genomic Data

Feb 09, 2016

|

NEW YORK (GenomeWeb) – Genomics England said today that it has selected Icon, a provider of drug development solutions and services to the pharmaceutical, biotechnology, and medical device industries, as its data management partner for the 100,000 Genomes Project.

Specifically, Icon will use its data management capabilities and its clinical trials expertise to validate clinical data from 70,000 cancer and rare disease patients and their families who are participating in the UK-led effort.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Letter Criticizes Actions

A letter criticizing actions by the US government and research institutions toward Chinese and Chinese-American scientists has garnered more than a hundred signatories.

Even Earlier Edits?

NPR reports that researchers in New York are investigating whether it is possible to edit the genomes of human sperm.

For Everyone

In an opinion piece at the Nation, Sarah Lawrence College's Laura Hercher argues that everyone should be able to access prenatal genetic testing.

Nature Studies Mystery of Remains Near Himalayan Lake, More

In Nature this week: ancient DNA uncovers presence of Mediterranean migrants at a Himalayan lake, and more.

Featured White Papers

10 Tips to Scale Your Diagnostics Business and Grow Your Test Portfolio Globally

Build vs. Buy? 6 Questions to Consider When Investigating Clinical Diagnostics Informatics Solutions

BlueBee Data Security & Compliance

Whole Genome Sequencing of Microbial Communities for Scaling Microbiome and Metagenomic Studies

Sep

18

Featured Webinar

Highly Sensitive Structural Variant Detection for Medical Genetics: A Comparison to the Standard of Care

This webinar will outline how a team at Radboud University Medical Center is assessing ultra-long read optical mapping on the Bionano Saphyr system to replace classical cytogenetics approaches in routine testing and for the discovery of novel structural variants with potential scientific, prognostic, or therapeutic value that are missed by standard approaches.

Oct

23

Featured Webinar

Single-Cell Methylation Profiling of Pediatric Tumors via a Unique NGS-based Approach

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.

Oct

24

Featured Webinar

Designing, Decoding & Delivering on Genetic Testing for Inherited Disease at Versiti

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

Menu